Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014)

Vertex Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $14.2 million for Q4 2014.

• On a quarterly basis, Current Taxes changed N/A year-over-year to $14.2 million in Q4 2014; TTM through Dec 2014 was $14.2 million, a N/A change from a year earlier, with the FY2014 full-year figure at $14.2 million, changed N/A from the prior year.
• Current Taxes climbed to $14.2 million in Q4 2014 per VRTX's latest filing, from $715000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $14.2 million in Q4 2014 and bottomed at $201000.0 in Q1 2012.
• The 3-year median for Current Taxes is $3.9 million (2012), against an average of $5.9 million.
• Biggest YoY gain for Current Taxes was 60.32% in 2012; the steepest drop was 94.08% in 2012.
• Year by year, Current Taxes stood at $12.1 million in 2011, then slumped by 94.08% to $715000.0 in 2012, then jumped by 1886.85% to $14.2 million in 2014.
• Per Business Quant, the three latest VRTX Current Taxes figures stand at $14.2 million (Q4 2014), $715000.0 (Q4 2012), and $3.9 million (Q3 2012).